Global Cord Blood
CORBF
$1.35
Share price
0.00%
Change (1 day)
-54.85%
Change (1 year)
Categories
Operating Margin for Global Cord Blood (CORBF)
Operating Margin as of April 2024 (TTM): 48.96%
According to Global Cord Blood's latest financial reports and stock price the company's current Operating Margin is 48.96%. At the end of 2022 the company had an Operating Margin of 50.50%.
Operating Margin history for Global Cord Blood from 2010 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 50.50% | -4.12% |
| 2021 | 52.67% | 11.14% |
| 2020 | 47.39% | 31.18% |
| 2019 | 36.12% | 11.49% |
| 2018 | 32.40% | 48.07% |
| 2017 | 21.88% | 2.66% |
| 2016 | 21.32% | -12.72% |
| 2015 | 24.42% | -26.72% |
| 2014 | 33.33% | 10.85% |
| 2013 | 30.07% | -24.54% |
| 2012 | 39.84% | 2.37% |
| 2011 | 38.92% | 27.77% |
| 2010 | 30.46% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 RadNet RDNT | 3.00% | -93.87% | 🇺🇸 USA |
 National Healthcare
NHC | 14.84% | -69.69% | 🇺🇸 USA |
 NeoGenomics
NEO | -31.26% | -163.85% | 🇺🇸 USA |
 Cryo-Cell CCEL | 9.04% | -81.54% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.